Patents by Inventor Remi Favier

Remi Favier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150232932
    Abstract: An in vitro method for diagnosing thrombocytopenia in a subject, the method includes the step of assessing the ANKRD26 platelet expression in a biological sample from the subject, wherein a ANKRD26 platelet expression is indicative of a thrombocytopenia. Also described is a kit for diagnosing a thrombocytopenia in a subject, which includes at least one ANKRD26 nucleic acid probe or oligonucleotide or antibody for assessing the ANKRD26 platelet expression in a biological sample from the subject.
    Type: Application
    Filed: September 17, 2013
    Publication date: August 20, 2015
    Applicant: INSTITUT GUSTAVE ROUSSY
    Inventors: Dominique Bluteau, Remi Favier, Hana Raslova, William Vainchenker
  • Publication number: 20130344494
    Abstract: A method of diagnosing a pathology resulting from a runt-related transcription factor 1 (RUNX1) inactivation in a subject, which includes the step of i) determining the platelets' myosin non-muscle heavy chain 10 (MYH10) expression level in a biological sample from the subject, and wherein a detectable platelets' MYH10 expression level is indicative of a pathology resulting from a runt-related transcription factor 1 (RUNX1) inactivation, and to a kit for diagnosing a pathology resulting from a runt-related transcription factor 1 (RUNX1) inactivation in a subject including i) at least one antibody for determining the platelet MYH10 expression level in a biological sample from the subject, which can be used in a such a method.
    Type: Application
    Filed: February 23, 2012
    Publication date: December 26, 2013
    Inventors: Dominique Bluteau, Yunchua Chang-Marchand, RĂ©mi Favier, Larissa Lordier, Hana Raslova, William Vainchenker